These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 35529790)

  • 21. RET-rearranged non-small-cell lung carcinoma: a clinicopathological and molecular analysis.
    Tsuta K; Kohno T; Yoshida A; Shimada Y; Asamura H; Furuta K; Kushima R
    Br J Cancer; 2014 Mar; 110(6):1571-8. PubMed ID: 24504365
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Will the Requirement by the US FDA to Simultaneously Co-Develop Companion Diagnostics (CDx) Delay the Approval of Receptor Tyrosine Kinase Inhibitors for RTK-Rearranged (ROS1-, RET-, AXL-, PDGFR-α-, NTRK1-) Non-Small Cell Lung Cancer Globally?
    Ou SH; Soo RA; Kubo A; Kawaguchi T; Ahn MJ
    Front Oncol; 2014; 4():58. PubMed ID: 24744988
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The genomic characteristics of RET fusion positive tumors in Chinese non-small cell lung cancer (NSCLC) patients.
    Wu G; Guo L; Gu Y; Huang T; Liu M; Zou X; Yang B; Huang P; Wen C; Yi L; Liao W; Zhao D; Zhu J; Zhang X; Liu Y; Yin Y; Chen S
    J Cancer Res Clin Oncol; 2023 Mar; 149(3):1019-1028. PubMed ID: 35220468
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Broad, Hybrid Capture-Based Next-Generation Sequencing Identifies Actionable Genomic Alterations in Lung Adenocarcinomas Otherwise Negative for Such Alterations by Other Genomic Testing Approaches.
    Drilon A; Wang L; Arcila ME; Balasubramanian S; Greenbowe JR; Ross JS; Stephens P; Lipson D; Miller VA; Kris MG; Ladanyi M; Rizvi NA
    Clin Cancer Res; 2015 Aug; 21(16):3631-9. PubMed ID: 25567908
    [TBL] [Abstract][Full Text] [Related]  

  • 25. IHC versus FISH versus NGS to detect ALK gene rearrangement in NSCLC: all questions answered?
    Batra U; Nathany S; Sharma M; Pasricha S; Bansal A; Jain P; Mehta A
    J Clin Pathol; 2022 Jun; 75(6):405-409. PubMed ID: 33753563
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical and Translational Implications of RET Rearrangements in Non-Small Cell Lung Cancer.
    Ferrara R; Auger N; Auclin E; Besse B
    J Thorac Oncol; 2018 Jan; 13(1):27-45. PubMed ID: 29128428
    [TBL] [Abstract][Full Text] [Related]  

  • 27. ALK FISH patterns and the detection of ALK fusions by next generation sequencing in lung adenocarcinoma.
    Dacic S; Villaruz LC; Abberbock S; Mahaffey A; Incharoen P; Nikiforova MN
    Oncotarget; 2016 Dec; 7(50):82943-82952. PubMed ID: 27769042
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinicopathologic implication of ALK rearrangement in surgically resected lung cancer: a proposal of diagnostic algorithm for ALK-rearranged adenocarcinoma.
    Paik JH; Choi CM; Kim H; Jang SJ; Choe G; Kim DK; Kim HJ; Yoon H; Lee CT; Jheon S; Choe JY; Chung JH
    Lung Cancer; 2012 Jun; 76(3):403-9. PubMed ID: 22129856
    [TBL] [Abstract][Full Text] [Related]  

  • 29. KIF5B/RET fusion gene analysis in a selected series of cytological specimens of EGFR, KRAS and EML4-ALK wild-type adenocarcinomas of the lung.
    Borrelli N; Giannini R; Proietti A; Alì G; Pelliccioni S; Niccoli C; Lucchi M; Melfi F; Mussi A; Basolo F; Fontanini G
    Lung Cancer; 2013 Sep; 81(3):377-381. PubMed ID: 23891510
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combinational Analysis of FISH and Immunohistochemistry Reveals Rare Genomic Events in ALK Fusion Patterns in NSCLC that Responds to Crizotinib Treatment.
    Li W; Zhang J; Guo L; Chuai S; Shan L; Ying J
    J Thorac Oncol; 2017 Jan; 12(1):94-101. PubMed ID: 27614248
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rearranged During Transfection Fusions in Non-Small Cell Lung Cancer.
    O'Leary C; Xu W; Pavlakis N; Richard D; O'Byrne K
    Cancers (Basel); 2019 May; 11(5):. PubMed ID: 31058838
    [TBL] [Abstract][Full Text] [Related]  

  • 32.
    Conde E; Hernandez S; Rodriguez Carrillo JL; Martinez R; Alonso M; Curto D; Jimenez B; Caminoa A; Benito A; Garrido P; Clave S; Arriola E; Esteban-Rodriguez I; De Castro J; Sansano I; Felip E; Rojo F; Dómine M; Abdulkader I; Garcia-Gonzalez J; Teixido C; Reguart N; Compañ D; Insa A; Mancheño N; Palanca S; Juan-Vidal O; Baixeras N; Nadal E; Cebollero M; Calles A; Martin P; Salas C; Provencio M; Aranda I; Massuti B; Lopez-Vilaro L; Majem M; Paz-Ares L; Lopez-Rios F
    JTO Clin Res Rep; 2024 Apr; 5(4):100653. PubMed ID: 38525319
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical Implications of Variant ALK FISH Rearrangement Patterns.
    Gao X; Sholl LM; Nishino M; Heng JC; Jänne PA; Oxnard GR
    J Thorac Oncol; 2015 Nov; 10(11):1648-52. PubMed ID: 26536196
    [TBL] [Abstract][Full Text] [Related]  

  • 34. KIF5B-RET fusions in Chinese patients with non-small cell lung cancer.
    Cai W; Su C; Li X; Fan L; Zheng L; Fei K; Zhou C
    Cancer; 2013 Apr; 119(8):1486-94. PubMed ID: 23378251
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association of genetic and immuno-characteristics with clinical outcomes in patients with RET-rearranged non-small cell lung cancer: a retrospective multicenter study.
    Lu C; Dong XR; Zhao J; Zhang XC; Chen HJ; Zhou Q; Tu HY; Ai XH; Chen XF; An GL; Bai J; Shan JL; Wang YN; Yang SY; Liu X; Zhuang W; Wu HT; Zhu B; Xia XF; Chen RR; Gu DJ; Xu HM; Wu YL; Yang JJ
    J Hematol Oncol; 2020 Apr; 13(1):37. PubMed ID: 32295619
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comprehensive NGS profiling to enable detection of
    Clavé S; Jackson JB; Salido M; Kames J; Gerding KMR; Verner EL; Kong EF; Weingartner E; Gibert J; Hardy-Werbin M; Rocha P; Riera X; Torres E; Hernandez J; Cerqueira G; Nichol D; Simmons J; Taus Á; Pijuan L; Bellosillo B; Arriola E
    Front Oncol; 2023; 13():1225646. PubMed ID: 37927472
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characteristics and outcomes of RET-rearranged Korean non-small cell lung cancer patients in real-world practice.
    Lee J; Ku BM; Shim JH; La Choi Y; Sun JM; Lee SH; Ahn JS; Park K; Ahn MJ
    Jpn J Clin Oncol; 2020 May; 50(5):594-601. PubMed ID: 32083304
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Alectinib activity in chemotherapy-refractory metastatic RET-rearranged non-small cell lung carcinomas: A case series.
    Ribeiro MFSA; Alessi JVM; Oliveira LJC; Gongora ABL; Sacardo KP; Zucchetti BM; Shimada AK; de Galiza Barbosa F; Feher O; Katz A
    Lung Cancer; 2020 Jan; 139():9-12. PubMed ID: 31698333
    [TBL] [Abstract][Full Text] [Related]  

  • 39. KIF5B-RET Fusion gene may coincide oncogenic mutations of EGFR or KRAS gene in lung adenocarcinomas.
    Kim JO; Lee J; Shin JY; Oh JE; Jung CK; Park JK; Sung SW; Bae SJ; Min HJ; Kim D; Park JY; Kang JH
    Diagn Pathol; 2015 Aug; 10():143. PubMed ID: 26268359
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeting RET in Patients With RET-Rearranged Lung Cancers: Results From the Global, Multicenter RET Registry.
    Gautschi O; Milia J; Filleron T; Wolf J; Carbone DP; Owen D; Camidge R; Narayanan V; Doebele RC; Besse B; Remon-Masip J; Janne PA; Awad MM; Peled N; Byoung CC; Karp DD; Van Den Heuvel M; Wakelee HA; Neal JW; Mok TSK; Yang JCH; Ou SI; Pall G; Froesch P; Zalcman G; Gandara DR; Riess JW; Velcheti V; Zeidler K; Diebold J; Früh M; Michels S; Monnet I; Popat S; Rosell R; Karachaliou N; Rothschild SI; Shih JY; Warth A; Muley T; Cabillic F; Mazières J; Drilon A
    J Clin Oncol; 2017 May; 35(13):1403-1410. PubMed ID: 28447912
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.